Estamos no ar no ! Saiba mais
Deslistada

EVOK foi retirado da bolsa em 16 de dezembro de 2025.

 

Sobre: Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Funcionários: 3

Notícias

Positivo
Neutro
Negativo
Sentimento 3 meses
Positivo 0%
Neutro 0%
Negativo 0%
Neutro
PRNewsWire
há 11 meses
Evoke Pharma and QOL Medical Announce Expiration of Tender Offer
Evoke Stockholders Received $11.00 Per Share in Cash SOLANA BEACH, Calif., and VERO BEACH, Fla.
Evoke Pharma and QOL Medical Announce Expiration of Tender Offer
Negativo
Proactive Investors
há 11 meses
William Hill owner Evoke puts business up for sale as gambling taxes weigh
Shares in William Hill owner Evoke PLC (LSE:EVOK) bounced 8% to 23.83p after the bookmaker confirmed that it is putting all or part of the company up for sale. A strategic review has been launched, the company said in a short statement, including "a range of potential alternatives to maximise shareholder value, including, but not limited to a potential sale of the group, or some of the company's assets and/or business units".
William Hill owner Evoke puts business up for sale as gambling taxes weigh
Negativo
Proactive Investors
há 11 meses
Entain, Evoke and Flutter warn of jobs cuts and illegal gambling due to Budget tax hike
Bookmakers Entain PLC (LSE:ENT), Evoke PLC (LSE:EVOK) and Flutter Entertainment PLC (LSE:FLTR, NYSE:FLUT) have warned investors of "highly damaging" consequences from the new UK gambling tax measures in yesterday's Budget, which are set to come into force from next April. Under changes announced in the autumn Budget, online gaming duty will rise to 40% from April 2026, and a new 25% remote betting duty will apply to online sports betting, excluding horse-racing, from April 2027.
Entain, Evoke and Flutter warn of jobs cuts and illegal gambling due to Budget tax hike
Negativo
Reuters
há 11 meses
Evoke assesses Italian unit sale amid tax concerns ahead of budget, Sky News reports
British bookmaker Evoke has appointed bankers to assess options for the potential sale of its Italian online business if the government imposes steep tax increases in the upcoming budget, Sky News reported on Tuesday.
Evoke assesses Italian unit sale amid tax concerns ahead of budget, Sky News reports
Neutro
GlobeNewsWire
ano passado
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Evoke Pharma, Inc. (NASDAQ: EVOK)
NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Evoke Pharma, Inc. (NASDAQ: EVOK ) related to its sale to QOL Medical, LLC. Under the terms of the proposed transaction, Evoke shareholders will receive $11.00 per share in cash. Is it a fair deal?
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Evoke Pharma, Inc. (NASDAQ: EVOK)
Neutro
PRNewsWire
ano passado
Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE , Nov. 4, 2025 /PRNewswire/ -- The Ademi Firm is investigating Evoke (NASDAQ: EVOK) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.
Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders
Neutro
Business Wire
ano passado
EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Evoke Pharma, Inc. (NASDAQ: EVOK) to QOL Medical, LLC for $11.00 per share in cash is fair to Evoke shareholders. Halper Sadeh encourages Evoke shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether Evoke and its boar.
EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders
Neutro
Business Wire
ano passado
MAI Capital Management Announces Expanded Office of Managing Partners Appointments Following Strategic Acquisition of Evoke Advisors
CLEVELAND--(BUSINESS WIRE)--Partnership creates national RIA with 600 employees and $65 billion in AUM.
MAI Capital Management Announces Expanded Office of Managing Partners Appointments Following Strategic Acquisition of Evoke Advisors
Negativo
Proactive Investors
ano passado
William Hill owner Evoke threatens betting shop closures if taxes go up
William Hill owner Evoke PLC (LSE:EVOK) has joined Ladbrokes owner Entain PLC (LSE:ENT) in threatening to close hundreds of betting shops if November's Budget brings new taxes on the industry.  The government says it is consulting on introducing new online betting taxes, bringing this more in line with taxes imposed in betting shops.
William Hill owner Evoke threatens betting shop closures if taxes go up
Neutro
Business Wire
ano passado
Evoke Advisors Ranked No. 1 on Forbes' ‘America's Top RIA Firms' List for Fourth Consecutive Year
LOS ANGELES--(BUSINESS WIRE)--Ranking recognizes Evoke's achievement in advancing client experience, and its leadership as a trusted advisor in the RIA industry.
Evoke Advisors Ranked No. 1 on Forbes' ‘America's Top RIA Firms' List for Fourth Consecutive Year
Gráficos de preços implementados com Lightweight Charts™